PARK MEDI WORLD LIMITED (NSE: PARKHOSPS, BSE: 544645) is a Gurugram, Haryana-based company in the Hospitals and Healthcare Centers industry. With a market capitalisation of ₹11,152 Cr, it ranks #563 by market cap among the 6,197 Indian listed companies on FinBizNet, and #11 of 46 in Hospitals and Healthcare Centers. At ₹255.00 (as of 16 Nov 2026), the share price is 16.4% below its 52-week high of ₹305.00 and 84.6% above its 52-week low of ₹138.10.
| Current Price | ₹255.00 |
|---|---|
| Market Cap | ₹11,152 Cr |
| NSE Symbol | PARKHOSPS |
| BSE Code | 544645 |
| Sector | Health Care > Health Care Equipment and Services > Health Care Providers and Services |
| Sub-Industry | Health Care Facilities > Hospitals and Healthcare Centers |
| P/E Ratio | 39.6 |
| Return on Equity | 13.00% |
| Return on Assets | 9.66% |
| 52-Week Range | ₹138.10 – ₹305.00 |
| 3-Month Price Change | -9.1% |
| Beta (1Y) | 0.72 |
| Headquarters | Gurugram, Haryana |
| Website | www.parkhospital.in |
| Revenue | ₹511 Cr |
|---|---|
| Net Profit | ₹54 Cr |
| Net Margin | 10.7% |
| EPS (Basic) | ₹1.26 |
| Basis | consolidated |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
PARK MEDI WORLD LIMITED reported revenue of ₹511 Cr in Q2 FY27, up 7.4% from ₹476 Cr in Q1 FY27. It posted a net profit of ₹54 Cr for the quarter, against a net profit of ₹89 Cr in Q1 FY27 (down 38.5%). Across the 4 quarters from Q3 FY26 to Q2 FY27, quarterly revenue ranged from ₹410 Cr (Q3 FY26) to ₹511 Cr (Q2 FY27). The company was profitable in each of these 4 quarters.
| Quarter | Revenue | Net Profit | Net Margin |
|---|---|---|---|
| Q2 FY27 | ₹511 Cr | ₹54 Cr | 10.7% |
| Q1 FY27 | ₹476 Cr | ₹89 Cr | 18.6% |
| Q4 FY26 | ₹460 Cr | ₹77 Cr | 16.7% |
| Q3 FY26 | ₹410 Cr | ₹53 Cr | 12.9% |
Consolidated figures (₹ crore, XBRL filings).
Promoters held 82.90% of PARK MEDI WORLD LIMITED's shares as of Sept 2026, against 82.89% in Dec 2025 (+0.01 percentage points). Delivery averaged 49.2% of traded volume across 16 NSE sessions (22 Oct 2026 – 13 Nov 2026).
Park Medi World Limited operates a network of hospitals. The company provides cardiac sciences, neurosciences - brain and spine, plastic and cosmetic surgery, general and laparoscopic surgery, renal sciences and kidney transplant, bone, orthopaedics, joint replacement and sports medicine, gastroenterology and surgical gastroenterology, cancer care, bone marrow transplant, iMARS / robot-assisted surgery. It also offers bariatric surgery, anaesthesiology, critical care, chest and respiratory diseases, dental care, dermatology, endocrinology, paediatrics, internal medicine and geriatrics, rheumatology, ENT, ophthalmology, obstetrics and gynaecology, interventional radiology and imaging, psychiatry, pathology and microbiology, paediatric surgery, fertility management, nuclear medicine services. It operates NABH accredited multi-super specialty hospitals under the Park brand name. Park Medi World Limited was founded in 2005 and is headquartered in Gurugram, India.
1. Healthcare Business-This segment owns, manages, and runs medical facilities. 2. NA-NA 3. NA-NA 4. NA-NA
1. Healthcare Business-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Apollo Hospitals Enterprise Limited | ₹1,23,712 Cr | 63 | 21.50% | ₹7,615 Cr | +11.6% |
| Max Healthcare Institute Ltd | ₹91,978 Cr | 63.9 | 14.33% | ₹2,569 Cr | -16.6% |
| Manipal Health Enterprises Ltd | ₹89,110 Cr | 88.4 | — | ₹3,399 Cr | — |
| Aster Dm Healthcare Limited (Asterdm) | ₹63,041 Cr | 97.6 | 10.07% | ₹2,829 Cr | +4.3% |
| Fortis Healthcare Ltd. | ₹58,283 Cr | 55.1 | 11.01% | ₹2,735 Cr | -25.1% |
| Global Health Ltd (Medanta) | ₹38,422 Cr | 69.7 | 15.03% | ₹1,469 Cr | +16.2% |
| Narayana Hrudayalaya Limited | ₹37,907 Cr | 46.2 | 19.85% | ₹2,844 Cr | +2.8% |
| Krishna Institute Of Medical Science (KIMS) | ₹29,056 Cr | 120.6 | 9.72% | ₹1,344 Cr | +0.2% |
| PARK MEDI WORLD LIMITED | ₹11,152 Cr | 39.6 | 13.00% | ₹511 Cr | — |
Listed by market capitalisation. Ratios are shown for context only.
PARK MEDI WORLD LIMITED is trading at ₹255.00, with a market capitalisation of ₹11,152 Cr.
PARK MEDI WORLD LIMITED operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Facilities > Hospitals and Healthcare Centers).
PARK MEDI WORLD LIMITED has a P/E of 39.6 and a return on equity of 13.00%.
PARK MEDI WORLD LIMITED is listed on the NSE under the symbol PARKHOSPS and on the BSE under the scrip code 544645.
In Q2 FY27, PARK MEDI WORLD LIMITED reported revenue of ₹511 Cr and net profit of ₹54 Cr, with basic EPS of ₹1.26 (consolidated, parsed from the company's exchange filing).
Promoters held 82.90% of PARK MEDI WORLD LIMITED's shares as of Sept 2026, against 82.89% in Dec 2025 (+0.01 percentage points).
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.